CN110157821B - Kit for detecting human staphylococcus - Google Patents
Kit for detecting human staphylococcus Download PDFInfo
- Publication number
- CN110157821B CN110157821B CN201910370166.5A CN201910370166A CN110157821B CN 110157821 B CN110157821 B CN 110157821B CN 201910370166 A CN201910370166 A CN 201910370166A CN 110157821 B CN110157821 B CN 110157821B
- Authority
- CN
- China
- Prior art keywords
- staphylococcus
- human
- kit
- sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Abstract
The invention provides a kit for detecting human staphylococci, which comprises guide RNA of a specific targeted human staphylococci rpoB gene, an amplification primer pair, a hydrated twist amp basic kit reaction dry ball, LbCas12a protein, a single-stranded DNA probe (ssDNA), a Ribonuclose Inhibitor and a buffer solution. The kit is used for detecting the human staphylococcus, has high detection specificity, and can distinguish the human staphylococcus from other staphylococcus, including staphylococcus aureus, staphylococcus epidermidis, staphylococcus wowensis, staphylococcus capitis and staphylococcus haemolyticus. Meanwhile, the RNA sequence of the invention is used for detection, the time consumption is about 1 hour, a PCR instrument is not needed, the requirement on equipment is low, the method is obviously lower than that of a traditional bacterial culture method or a PCR sequencing method, and the clinical practical value is high.
Description
Technical Field
The invention belongs to the field of pathogenic bacteria detection, and relates to a kit for detecting human staphylococci, which comprises guide RNA of a specific targeted human staphylococci rpoB gene, an RPA amplification primer pair, a hydrated twist Amp basic kit reaction dry ball, LbCas12a protein, a single-stranded DNA probe (ssDNA), a Ribonucleae Inhibitor and buffer solution. The kit can be used for quickly detecting the staphylococcus hominis.
Background
Human staphylococcus is a common flora in gram-positive bacteria infected by human bodies, and brings huge burden to patients and society. The traditional detection method is to carry out bacterial culture or PCR combined sequencing, but the bacterial culture needs 5-7 days, and the PCR often cannot distinguish the human staphylococcus from other staphylococcus due to lack of specific primers, so the identification can be carried out only by combined first-generation sequencing, the cost is high, and the result can be obtained only in several days. During this period, the clinician can only administer the drug empirically because no test results are obtained, often resulting in delayed treatment of the disease. Therefore, how to rapidly detect the human staphylococcus is very important. Recently, Zhang Feng et al found that the LbCas12a protein can be used for detecting pathogenic bacteria, and the detection can be completed in about 1 hour, so that the time and the labor are saved, and the sensitivity is high. The specific principle is that the system comprises LbCas12a protein, pathogenic bacteria DNA, guide RNA and single-stranded DNA (ssDNA) with a fluorescent group and a quenching group at two ends respectively. Wherein, the DNA sequence of the pathogenic bacteria needs to contain a PAM structure of TTTN, and the sequence needs to have specificity, namely to be distinguished from other pathogenic bacteria. The guide RNA sequence is a sequence behind TTTN in the specific target sequence of the pathogenic bacteria, and the length of the guide RNA sequence is 20-24 basic groups. Under the guidance of guide RNA, LbCas12a protein can be combined to a pathogen-specific DNA sequence, and then LbCas12a protein can show Dnase activity, so that single-stranded DNA with a fluorescent group and a quenching group at two ends is cut, the fluorescent group and the quenching group are separated, fluorescence is generated, and the existence of a pathogen is indicated.
Disclosure of Invention
The invention aims to provide a kit for detecting human staphylococci, which comprises guide RNA specifically targeting a human staphylococci rpoB gene, an RPA amplification primer pair, a hydrated twist amp basic kit reaction dry ball, LbCas12a protein, a single-stranded DNA probe (ssDNA), a ribonuclear Inhibitor and a buffer solution. The nucleotide sequence of the guide RNA of the specific targeting human staphylococcus rpoB gene is shown in SEQ No.1, can specifically target human staphylococcus, but can not target staphylococcus aureus, staphylococcus epidermidis, staphylococcus wowensis, staphylococcus capitis and staphylococcus haemolyticus, and can be used for detecting the human staphylococcus. The RPA amplification primer pair RPA-F and RPA-R has the sequence shown in SEQ No.2 and SEQ No. 3. The sequence of the single-stranded DNA probe is shown in SEQ No. 6.
The invention also aims to provide a method for rapidly detecting staphylococcus hominis based on the kit, which is realized by the following steps:
the method comprises the following specific steps: 1ml of the sample was heated at 95-98 ℃ for 5min, 1. mu.l of the sample was used as a test sample, and 14.75. mu.l of hydrated twist Amp basic kit reaction dry spheres (twist Dx Co.), 0.9. mu.l of 10mM RPA-F (SEQ ID NO: 2) and RPA-R (SEQ ID NO: 3), 0.375. mu.l of Ribonuclase Inhibitor (Takara Co.), 3.5. mu.l of buffer2.1(NEB Co.), 1000nM guide RNA (SEQ ID NO: 1), 250nM Cas12a (NEB Co.), 200nM single-stranded DNA probe (Shanghai Biolabs, SEQ ID NO: 6) were added with water to make up to 25. mu.l. Reacting at 37 ℃ for 25-45min, and detecting staphylococcus hominis by directly observing the fluorescence change of a detection system under a fluorescence microscope; the yellow green fluorescence indicates that the staphylococcus hominis is polluted, and the non-luminescence indicates that the staphylococcus hominis is not polluted. The method can distinguish Staphylococcus hominis from other Staphylococcus including Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus wovensis, Staphylococcus capitis, and Staphylococcus haemolyticus.
Wherein:
the single-stranded DNA probe ssDNA sequence (SEQ No.6) is: 5 '6-FAM-TTATT-3' BHQ1, synthesized by Shanghai.
The detection kit for detecting the staphylococcus hominis infection has the advantages that:
(1) compared with the traditional bacterial culture or PCR combined one-generation sequencing method, the traditional method needs several days, and the method can complete detection in 1 hour. Meanwhile, the method adopts the RPA method for amplification, the reaction can be completed only by a constant-temperature water bath kettle, a PCR instrument is not needed, and the requirement on equipment is low.
(2) When the detection kit is used for detection, only human staphylococcus is in a positive reaction, and other staphylococcus, including common staphylococcus aureus, staphylococcus epidermidis, staphylococcus wowensis, staphylococcus capitis and staphylococcus haemolyticus, are in negative reactions. Therefore, the detection kit has high specificity.
Drawings
FIG. 1 is a comparison chart of rpoB gene sequences of human staphylococcus, staphylococcus aureus, staphylococcus epidermidis, staphylococcus wadskii, staphylococcus capitis and staphylococcus haemolyticus.
FIG. 2 shows the result of fluorescence microscopy, wherein the staphylococcus strains, such as Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus wovensis, Staphylococcus capitis, and Staphylococcus haemolyticus, are added from tube Nos. 1-6. Wherein, tube No.1 has yellow green fluorescence and shows positive reaction. No. 2-6 tubes have no yellow green fluorescence and show negative reaction.
FIG. 3 shows that different species of staphylococci were amplified by PCR method to obtain bands with similar sizes, which could not distinguish human staphylococci.
FIG. 4 is a graph showing the comparison of the time consumption of the experiment using the detection method based on the guide RNA of the present invention and the conventional PCR sequencing method in combination.
Detailed Description
The invention is further described below with reference to the figures and examples.
Example 1: alignment of staphylococcal rpoB Gene sequences
As shown in FIG. 1, in the human staphylococcal rpoB gene sequence, 5' end of the guide RNA sequence (selected part) of the invention is PAM structure of TTTN. The guide RNA sequences have no completely identical sequences in staphylococcus aureus, staphylococcus epidermidis, staphylococcus wowensis, staphylococcus capitis and staphylococcus haemolyticus, and all have differences of several bases. And 5' ends of homologous sequences in staphylococcus aureus, staphylococcus epidermidis, staphylococcus wowensis, staphylococcus capitatum and staphylococcus haemolyticus are all free of a PAM structure of TTTN, so that by using the guide RNA, the Cas12a protein cannot target the staphylococcus aureus, staphylococcus epidermidis, staphylococcus wowensis, staphylococcus capitis and staphylococcus haemolyticus, and only human staphylococcus can show positive reaction while other staphylococcus can show negative reaction during detection. As shown in FIG. 1, the 5' end of the sequence (in the box-selected part of the figure) is a PAM sequence of TTTN structure on human Staphylococcus rpoB gene, and the sequence is not present in Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus wovensis, Staphylococcus capitis, and Staphylococcus haemolyticus, which are commonly found in Staphylococcus. In addition, in other staphylococcus, the 5' end of the homologous sequence of the sequence does not contain a PAM structure of TTTN, so that the sequence can specifically target staphylococcus hominis but cannot target staphylococcus aureus, staphylococcus epidermidis, staphylococcus wowensis, staphylococcus capitis and staphylococcus haemolyticus, and can be used for specific detection of staphylococcus hominis.
Example 2: the guide RNA specificity determination method comprises the following steps:
(1) preparing standard strains of human staphylococcus, staphylococcus aureus, staphylococcus epidermidis, staphylococcus wowensis, staphylococcus capitis and staphylococcus haemolyticus;
(2) taking 1ml of a sample to be detected, heating at 98 ℃ for 5min, and sucking 1 mu l of the sample to be detected as a detection sample;
(3) preparing a reaction system, the reaction system being 25. mu.l comprising 1. mu.l of a test sample, 14.75. mu.l of hydrated twist Amppasic kit reaction dry spheres (twist Dx Co.), 0.9. mu.l of 10mM RPA-F (SEQ No.2) and RPA-R (SEQ No.3), 0.375. mu.l of Ribonucleae Inhibitor (Takara Co.), 3.5. mu.l of buffer2.1(NEB Co.), 1000nM guide RNA (SEQ No.1), 250nM Cas12a (NEB Co.), 200nM single-stranded DNA probe (Shanghai Producer), and adding water to 25. mu.l;
(4) reacting at 37 ℃ for 30 min;
(5) after the reaction is finished, the PCR tube is placed under a fluorescence microscope for direct observation, the existence of the human staphylococcus is proved by fluorescence, and the absence of the fluorescence indicates that the human staphylococcus is not polluted.
The detection result is shown in FIG. 2, and the sample 1 is human Staphylococcus, and fluorescence is observed, and a positive reaction is shown. The rest samples are non-human staphylococcus, have no fluorescence and show negative reaction.
Example 3 detection of guide RNA based on the invention compared with the conventional PCR method in specificity and time consuming experiments
1. The method for detecting the guide RNA based on the invention comprises the following steps:
(1) preparing standard strains of human staphylococcus, staphylococcus aureus, staphylococcus epidermidis, staphylococcus wowensis, staphylococcus capitis and staphylococcus haemolyticus;
(2) taking 1ml of a sample to be detected, heating at 98 ℃ for 5min, and sucking 1 mu l of the sample to be detected as a detection sample;
(3) preparing a reaction system, the reaction system being 25. mu.l comprising 1. mu.l of a test sample, 14.75. mu.l of hydrated twist Amppasic kit reaction dry spheres (twist Dx Co.), 0.9. mu.l of 10mM RPA-F (SEQ No.2) and RPA-R (SEQ No.3), 0.375. mu.l of Ribonucleae Inhibitor (Takara Co.), 3.5. mu.l of buffer2.1(NEB Co.), 1000nM guide RNA (SEQ No.1), 250nM Cas12a (NEB Co.), 200nM single-stranded DNA probe (Shanghai Producer), and adding water to 25. mu.l;
(4) reacting at 37 ℃ for 30 min;
(5) after the reaction is finished, the PCR tube is placed under a fluorescence microscope for direct observation, the existence of the human staphylococcus is proved by fluorescence, and the absence of the fluorescence indicates the pollution of the human staphylococcus;
(6) the detection result is shown in FIG. 2, and the sample 1 is human Staphylococcus, and fluorescence is observed, and a positive reaction is shown. The rest samples are non-human staphylococcus, have no fluorescence and show negative reaction.
2. The traditional PCR method comprises the following experimental steps:
(1) designing a primer, wherein the sequence of the PCR primer is 20 bases initiated at the 5' end of the RPA primer, so that the obtained PCR product has the same sequence with the RPA product, and the sequence of a primer pair is shown in SEQ No.4 and SEQ No. 5;
(2) taking 1ml of a sample to be detected, heating at 98 ℃ for 5min, and sucking 1 mu l of the sample to be detected as a detection sample;
(3) preparing a reaction system, wherein the reaction system comprises 12.5 mul of DNA polymerase premix (Shanghai works), 1 mul of forward primer, 1 mul of reverse primer, 1 mul of sample to be detected and 9.5 mul of water;
(4) carrying out PCR reaction;
(5) performing agarose gel electrophoresis;
(6) as shown in FIG. 3, 272bp fragments were amplified from all samples, and it was impossible to distinguish Staphylococcus hominis from Staphylococcus aureus.
As mentioned above, the PCR method cannot distinguish the species of staphylococci, so sequencing comparison is required, the experiment cost is high, the time is long, and the disease condition may be delayed.
As shown in FIG. 4, the detection method using the detection kit of the present invention has high specificity and takes a short time of only about 1 hour, while the PCR method is used, since the sequences of different species of staphylococci are highly homologous, the difference in a sequence is often only a few bases, the designed primers can be amplified by all strains, the obtained products are close in size and cannot be distinguished by agarose gel, and thus the sequencing is required, and the experiment takes about 2 days. The method of the invention takes significantly less time than the PCR group.
Sequence listing
<110> Zhejiang university
<120> a kit for detecting human staphylococcus
<160>6
<170>SIPOSequenceListing 1.0
<210>1
<211>20
<212>RNA
<213> Artificial sequence (Unknown)
<400>1
<210>2
<211>32
<212>DNA
<213> Artificial sequence (Unknown)
<400>2
gttcctgaag aagatatgcc ttacttacca ga 32
<210>3
<211>32
<212>DNA
<213> Artificial sequence (Unknown)
<400>3
cgattatcaa atggttcacc agtacgtcca tc 32
<210>4
<211>20
<212>DNA
<213> Artificial sequence (Unknown)
<400>4
<210>5
<211>20
<212>DNA
<213> Artificial sequence (Unknown)
<400>5
<210>6
<211>5
<212>DNA
<213> Artificial sequence (Unknown)
<400>6
ttatt 5
Claims (1)
1. A kit for detecting human staphylococci is characterized by comprising guide RNA of a specific targeted human staphylococci rpoB gene, an amplification primer pair, a hydrated twist amp basic kit reaction dry ball, LbCas12a protein, a single-stranded DNA probe, a Ribonucleae Inhibitor and a buffer solution; wherein the nucleotide sequence of the guide RNA of the specific targeting human staphylococcus rpoB gene is shown as SEQ No.1, the sequence of the RPA amplification primer pair is shown as SEQ No.2 and SEQ No.3, and the sequence of the single-stranded DNA probe is shown as SEQ No. 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910370166.5A CN110157821B (en) | 2019-05-06 | 2019-05-06 | Kit for detecting human staphylococcus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910370166.5A CN110157821B (en) | 2019-05-06 | 2019-05-06 | Kit for detecting human staphylococcus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110157821A CN110157821A (en) | 2019-08-23 |
| CN110157821B true CN110157821B (en) | 2020-08-28 |
Family
ID=67633680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910370166.5A Expired - Fee Related CN110157821B (en) | 2019-05-06 | 2019-05-06 | Kit for detecting human staphylococcus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110157821B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111505299B (en) * | 2020-04-29 | 2022-09-06 | 上海理工大学 | Human staphylococcus immune colloidal gold fast detection test paper strip |
| CN112961929B (en) * | 2021-05-18 | 2021-08-10 | 至善时代智能科技(北京)有限公司 | Primer group, kit and method for staphylococcus in species level identification environment |
| CN112980982B (en) * | 2021-05-18 | 2021-08-10 | 至善时代智能科技(北京)有限公司 | Primers and detection kit for identifying multiple staphylococci based on pheS gene and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107164512A (en) * | 2017-06-22 | 2017-09-15 | 上海市食品药品检验所 | A kind of identification of staphylococcus kind level and strain typing integral method based on SNP |
| CN107488710A (en) * | 2017-07-14 | 2017-12-19 | 上海吐露港生物科技有限公司 | A kind of purposes of Cas albumen and the detection method and kit of target nucleic acids molecule |
| CN109251963A (en) * | 2018-11-12 | 2019-01-22 | 复旦大学 | The method and kit of mycoplasma contamination in Constant Temperature Detection cell culture fluid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2829148B1 (en) * | 2001-09-06 | 2004-10-15 | Univ Aix Marseille Ii | MOLECULAR IDENTIFICATION OF STAPHYLOCOCCUS BACTERIA |
| US7888075B2 (en) * | 2007-07-31 | 2011-02-15 | Quest Diagnostics Investments Incorporated | Detection of methicillin-resistant and methicillin-sensitive Staphylococcus aureus in biological samples |
-
2019
- 2019-05-06 CN CN201910370166.5A patent/CN110157821B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107164512A (en) * | 2017-06-22 | 2017-09-15 | 上海市食品药品检验所 | A kind of identification of staphylococcus kind level and strain typing integral method based on SNP |
| CN107488710A (en) * | 2017-07-14 | 2017-12-19 | 上海吐露港生物科技有限公司 | A kind of purposes of Cas albumen and the detection method and kit of target nucleic acids molecule |
| CN109251963A (en) * | 2018-11-12 | 2019-01-22 | 复旦大学 | The method and kit of mycoplasma contamination in Constant Temperature Detection cell culture fluid |
Non-Patent Citations (2)
| Title |
|---|
| CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity;Janice S. Chen等;《Science》;20180215;第360卷(第6387期);摘要，第438页左栏第2段至右栏最后一段，图4 * |
| rpoB Gene Sequence-Based Identification of Staphylococcus Species;Michel Drancourt等;《JOURNAL OF CLINICAL MICROBIOLOGY》;20020430;第40卷(第4期);摘要，第1335页右栏第2-3段，第1336页左栏第1段，图1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110157821A (en) | 2019-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110079586B (en) | Kit for detecting staphylococcus aureus | |
| Jensen et al. | Rapid identification of bacteria on the basis of polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms | |
| CN110157821B (en) | Kit for detecting human staphylococcus | |
| CN110541022A (en) | mycobacterium tuberculosis complex detection kit based on CRISPR-Cas12a system | |
| CN110241239B (en) | Kit for detecting enterobacter cloacae | |
| US10253376B2 (en) | DNA-based detection and identification of eight mastitis pathogens | |
| CN110129462B (en) | Kit for detecting staphylococcus haemolyticus | |
| CN110241237B (en) | Kit for detecting enterobacter aerogenes | |
| CN101613766A (en) | A kind of RT-LAMP test kit of PPR virus | |
| CN110408727B (en) | CPA primer group for detecting J subgroup avian leukosis virus, CPA nucleic acid test strip kit and application thereof | |
| CN110144416B (en) | Kit for detecting staphylococcus wowensis | |
| CN110157822B (en) | Kit for detecting staphylococcus epidermidis | |
| CN110129463B (en) | Kit for detecting staphylococcus capitis | |
| RU2612137C1 (en) | Method for identification of tularemia pathogen subspecies francisella tularensis subsp tularensis, francisella tularensis subsp mediasiatica and francisella tularensis subsp holarctica | |
| CN110241238B (en) | Kit for detecting streptococcus pyogenes | |
| CN110863061A (en) | Specific LAMP primer, kit and method for detecting staphylococcus aureus | |
| JP2018503363A (en) | Compositions and methods for detecting mecC-containing methicillin-resistant Staphylococcus aureus | |
| JP2015213439A (en) | Lamp primer for detecting staphylococcus aureus having enterotoxin b, c, d, or e gene, or genes thereof, and method for detecting staphylococcus aureus having enterotoxin b, c, d, or e gene, or genes thereof using the same | |
| CN110317890A (en) | A kind of kit for enterococcus faecalis detection | |
| CN108913790B (en) | Recombinase polymerase isothermal amplification method for detecting coxiella burnetii, special primer and probe and application | |
| CN101892313B (en) | Method for fast detecting trypanosome evansi by utilizing loop-mediated isothermal application technology | |
| Chen et al. | Development of a closed-tube isothermal multiple self-matching-initiated amplification assay for visual detection of Staphylococcus aureus in milk samples | |
| CN110331219A (en) | A kind of kit for pseudomonas aeruginosa detection | |
| Van Nguyen et al. | Development and clinical validation of a DNA gyrase subunit B gene based loop-mediated isothermal amplification method for detection of Melissococcus plutonius | |
| CN110358848A (en) | A kind of kit for enterococcus faecium detection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200828 |